Research interests include Nanoplatforms for cancer theranostics, Cancer survivorship and care, RNA modifications and cancer, and MicroRNA in disease regulation.
Deciphering the role of <i>ELAVL1</i>: Insights from pan-cancer multiomics analyses with emphasis on nasopharyngeal carcinoma
Journal of Translational Internal Medicine2025cited by 20position: middledoi
Multi‐omics analysis of disulfidptosis regulators and therapeutic potential reveals glycogen synthase 1 as a disulfidptosis triggering target for triple‐negative breast cancer